| Date | Title | Description | |
|---|---|---|---|
| 16 Feb 2023 | On business and financial situation | The Company informs on the evaluation process to obtain marketing authorisation for Risvan® (Risperidone ISM®) in the United States. | Download |
| 09 Jan 2023 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the fourth quarter of 2022 | Download |
| 15 Dec 2022 | On Corporate Governance | The Company informs about changes in the Board of Directors and the creation of an Advisory Committee. | Download |
| 04 Oct 2022 | On business and financial situation | The Company informs that it has signed a joint venture agreement with Càrniques Ceirà and Grupo Costa to construct a plant for the production of compounds of high technological value. | Download |
| 03 Oct 2022 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the third quarter of 2022 | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 25 Jul 2017 | Otros sobre Gobierno Corporativo | The Company informes about the modification of the Internal code of conduct | Download |
| 10 Jul 2017 | Contratos de liquidez y contrapartida (2) | The Company informs that has signed a new liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. | Download |
| 10 Jul 2017 | Contratos de liquidez y contrapartida (1) | The Company informs that has cancelled the liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. | Download |
| 04 Jul 2017 | Contratos de liquidez y contrapartida | Liquidity contract: transactions conducted in the second quarter of 2017 | Download |
| 23 Jun 2017 | Información sobre dividendos | The Company informes about the dividends payment | Download |